Determinants of depressive symptoms increase in older persons during the COVID-19 pandemic: evidence from Czech cohort study using repeated assessments

DALECKÁ, Andrea; Hynek PIKHART; Anna BARTOŠKOVÁ; Naděžda ČAPKOVÁ a Martin BOBÁK. Determinants of depressive symptoms increase in older persons during the COVID-19 pandemic: evidence from Czech cohort study using repeated assessments. Journal of Epidemiology and Community Health. BMJ Publishing Group, 2023, roč. 77, č. 2, s. 101-107. ISSN 0143-005X. Dostupné z: https://doi.org/10.1136/jech-2022-219412.

Základní údaje

Originální název

Determinants of depressive symptoms increase in older persons during the COVID-19 pandemic: evidence from Czech cohort study using repeated assessments

Autoři

DALECKÁ, Andrea; Hynek PIKHART; Anna BARTOŠKOVÁ; Naděžda ČAPKOVÁ a Martin BOBÁK

Vydání

Journal of Epidemiology and Community Health, BMJ Publishing Group, 2023, 0143-005X

---

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.900

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/23:00130079

Organizační jednotka

Přírodovědecká fakulta

DOI

https://doi.org/10.1136/jech-2022-219412

UT WoS

000890992900001

EID Scopus

2-s2.0-85144790993

Klíčová slova anglicky

COVID-19 pandemic; depressive symptoms; longitudinal studies

Štítky

143180, rivok

Příznaky

Mezinárodní význam, Recenzováno

---

Anotace

V originále

Numerous studies reported higher levels of mental health issues during the COVID-19 pandemic but only a minority used repeated measurements. We investigated change in depressive symptoms in the Czech ageing cohort and the impact of pre-existing and COVID-19-related stressors. We used data on 2853 participants (mean age 73.4 years) from the Czech part of the prospective Health, Alcohol and Psychosocial factors In Eastern Europe cohort that participated in postal questionnaire surveys before (September 2017–June 2018) and during the pandemic (October 2020–April 2021). Participants reported their depressive symptoms using the Centre for Epidemiological Studies-Depression Scale including 10 (CESD-10) tool. A principal component analysis (PCA) was used to create representative components of the pandemic-related stressors. The impact of the stressors on change in depressive symptoms was tested using multivariable linear regression, after adjustment for age and potential confounders. Three patterns of the pandemic-related stressors (‘financial stressors’, ‘social and perception stressors’ and ‘death and hospitalisation stressors’) were extracted from the PCA. The mean CESD-10 score increased from 4.90 to 5.37 (p<0.001). In fully adjusted models, significantly larger increases in depression score were reported by older people (β=0.052; p=0.006), those with poor self-rated health (β=0.170; p<0.001), those who experienced death or hospitalisation of a close person (β=0.064; p<0.001), social deprivation (β=0.057; p<0.001), delays in healthcare (β=0.048; p=0.005) and those who suffered from COVID-19 (β=0.045; p=0.008). This study confirms an increase in depressive symptoms in older persons during the pandemic and identified several pandemic-related risk factors suggesting that public health policies should address this vulnerable group by adopting the preventing strategies.

---

Návaznosti

EF17_043/0009632, projekt VaV	Název: CETOCOEN Excellence
LX22NPO5101, projekt VaV	Název: Národní institut pro výzkum socioekonomických dopadů nemocí a systémových rizik (Akronym: SYRI) Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní institut pro výzkum socioekonomických dopadů nemocí a systémových rizik, 5.1 EXCELES
857340, interní kód MU	Název: External and Internal Human Exposure in Urban EXposome (Akronym: Urban_X) Investor: Evropská unie, External and Internal Human Exposure in Urban EXposome, Spreading excellence and widening participation
857487, interní kód MU	Název: R-Exposome Chair: Unlocking the potential of RECETOX in Exposome research (Akronym: R-Exposome Chair) Investor: Evropská unie, R-Exposome Chair: Unlocking the potential of RECETOX in Exposome research, Spreading excellence and widening participation
857560, interní kód MU (Kód CEP: EF17_043/0009632)	Název: CETOCOEN Excellence (Akronym: CETOCOEN Excellence) Investor: Evropská unie, CETOCOEN Excellence, Spreading excellence and widening participation
90121, velká výzkumná infrastruktura	Název: RECETOX RI

Přiložené soubory

2233817.pdf

Práva souboru pro čtení

×